查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1578936

單細胞試劑套件市場：按產品類型、技術和最終用戶 - 2025-2030 年全球預測

Single Cell Kit Market by Product Type (Instruments, Reagents And Kits), Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年單細胞套件市值為15.4億美元，預計2024年將達到17.3億美元，複合年成長率為11.12%，到2030年將達到32.3億美元。

單細胞套件市場的範圍和定義包括為分析單一細胞而設計的工具和技術，提供對細胞功能、遺傳物質和微環境的深入了解。對單細胞套件的需求主要是由精準醫學、藥物發現和先進基因組研究日益成長的需求所驅動的。這些套件的應用涵蓋生物技術、製藥和學術領域，最終用途為實驗室、醫院和診斷中心。主要市場影響包括生物技術的快速進步、研發資金的增加以及個人化醫療需求的快速成長。

主要市場統計
基準年[2023] 15.4億美元
預測年份 [2024] 17.3億美元
預測年份 [2030] 32.3億美元
複合年成長率（%） 11.12%

將人工智慧和機器學習與單細胞分析相結合以得出預測分析，從而增強臨床環境中的決策，並存在重大的成長機會。此外，將應用擴展到免疫學、癌症研究和發育生物學也是一個有前途的途徑。微流體和具有成本效益的高通量測序的創新也至關重要，並且有可能使單細胞技術更容易獲得和高效。

然而，這個市場並非沒有挑戰。單細胞分析的高成本和缺乏標準化可能會阻礙生長。與資料分析和解釋相關的技術複雜性也對廣泛採用構成了障礙。為了克服這些限制，建議投資開發強大的生物資訊工具並促進學術、臨床和工業合作。

市場的特點是技術創新快、競爭激烈，需要不斷改進和適應。因此，公司應優先研究和開發單細胞分析新方法，特別是那些解決可擴展性和準確性的方法。透過專注於新興市場並專注於與主要相關人員合作進行技術整合，預計將實現顯著成長。隨著精準醫學的不斷發展，單細胞套件的重要性將會增加，從而推動進一步的研究和市場擴張機會。

市場動態：揭示快速發展的單細胞套件市場的關鍵市場洞察

單細胞套件市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 單細胞分析技術的進步正在推動對更精確的單細胞套件的需求。
    • 單細胞套件在癌症研究和個人化醫療中的廣泛應用推動了市場成長
    • 增加政府和私人對單細胞基因組學研究的資助，以加速套件開發
    • 學術和研究機構擴大採用單細胞套件進行複雜的生物學研究
  • 市場限制因素
    • 圍繞單細胞研究的監管和道德擔憂減緩了市場成長
    • 缺乏標準化方案和程序會影響單細胞分析結果的可靠性
  • 市場機會
    • 對精準醫療和個人化醫療保健的需求不斷成長將推動單細胞試劑套件市場
    • 增加對單細胞基因組學研究的投資加速了單細胞套件市場的成長
    • 單細胞分析的技術進步擴大了單細胞套件的使用與採用
  • 市場挑戰
    • 資料管理和分析工具在處理、儲存和解釋資訊方面的複雜性
    • 單細胞實驗方案和工作流程缺乏標準化

波特五力：駕馭單細胞試劑套件市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解單細胞套件市場的外部影響

外部宏觀環境因素在塑造單細胞套件市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解單細胞套件市場的競爭狀況

對單細胞套件市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣單細胞套件市場供應商績效評估

FPNV定位矩陣是評估單細胞套件市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了單細胞套件市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對單細胞試劑套件市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 單細胞分析技術的進步增加了對更準確的單細胞套件的需求。
      • 擴大單細胞套件在癌症研究和個人化醫療的應用將推動市場成長
      • 增加政府和私人對單細胞基因組研究的資助將加速套件的開發
      • 學術研究實驗室更採用單細胞套件進行複雜的生物研究
    • 抑制因素
      • 圍繞單細胞研究的監管和道德擔憂減緩了市場成長
      • 缺乏標準化的通訊協定和程序會影響單細胞分析結果的可靠性。
    • 機會
      • 對精準醫療和個人化醫療保健的需求不斷成長推動單細胞套件市場
      • 增加單細胞基因組研究的投資推動單細胞套件市場
      • 單細胞分析的技術進步正在擴大單細胞套件的使用和採用。
    • 任務
      • 資料管理和分析工具在處理、儲存和解釋資訊方面的複雜性
      • 單細胞通訊協定和工作流程缺乏標準化
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章單細胞套件市場：依產品類型

  • 裝置
    • 細胞計數器
    • 流式細胞儀
    • 顯微鏡
  • 試劑和套件
    • 放大套件
    • 細胞裂解套件
    • 文庫製備試劑套件
    • 核酸萃取試劑套件

第7章單細胞試劑套件市場：依技術分類

  • 次世代定序（NGS）
    • EXOME定序
    • RNA定序
    • 單細胞DNA定序
    • 全基因組序列分析
  • 聚合酵素鏈鎖反應(PCR)
    • 數位PCR
    • 即時PCR

第8章單細胞試劑套件市場：依最終用戶分類

  • 學術研究所
    • 調查機構
    • 大學
  • 合約調查機構
    • 外包調查服務
  • 醫院和診斷實驗室
    • 臨床診斷
    • 病理實驗室
  • 製藥和生物技術公司
    • 藥物開發
    • 藥物發現

第9章美洲單細胞套件市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太單細胞試劑套件市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲單細胞套件市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 10x Genomics
  • Abcam plc
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Berkeley Lights
  • Bio-Rad Laboratories, Inc.
  • Dolomite Bio
  • Fluidigm Corporation
  • Horizon Discovery
  • Illumina, Inc.
  • Miltenyi Biotec
  • Mission Bio
  • NanoString Technologies
  • Partek Incorporated
  • Promega Corporation
  • QIAGEN
  • Sphere Fluidics
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • WaferGen Biosystems
Product Code: MRR-2B5802CFEA3A

The Single Cell Kit Market was valued at USD 1.54 billion in 2023, expected to reach USD 1.73 billion in 2024, and is projected to grow at a CAGR of 11.12%, to USD 3.23 billion by 2030.

The scope and definition of the single-cell kit market involve tools and technologies designed for the analysis of individual cells, providing deep insights into cellular function, genetic material, and the microenvironment. The necessity for single-cell kits primarily stems from the growing need for precision medicine, drug discovery, and advanced genomic research, as they enable scientists to study cellular heterogeneity which is crucial for understanding complex biological systems and diseases like cancer. The application of these kits extends across biotechnology, pharmaceuticals, and academic sectors, with their end-use spanning research laboratories, hospitals, and diagnostic centers. The key market influences include the rapid advancements in biotechnology, increased funding for R&D, and the surging demand for personalized medicine.

KEY MARKET STATISTICS
Base Year [2023] USD 1.54 billion
Estimated Year [2024] USD 1.73 billion
Forecast Year [2030] USD 3.23 billion
CAGR (%) 11.12%

Significant growth opportunities exist in integrating artificial intelligence and machine learning with single-cell analysis to derive predictive analytics, thereby enhancing decision-making in clinical settings. Additionally, expanding applications in immunology, cancer research, and developmental biology represent promising avenues. Innovations in microfluidics and cost-effective, high-throughput sequencing are also pivotal, offering potential to make single-cell technologies more accessible and efficient.

However, the market is not without challenges. High costs associated with single-cell analysis and a lack of standardization could hinder growth. Technical complexities involved in data analysis and interpretation also present barriers to widespread adoption. To overcome these limitations, investments in developing robust bioinformatics tools and fostering collaborations among academic, clinical, and industrial entities are recommended.

The market is characterized by a blend of rapid innovation and high competition, demanding continuous improvement and adaptation. Therefore, businesses should prioritize R&D in new methodologies for single-cell analysis, particularly those addressing scalability and accuracy. Emphasizing alliances with key stakeholders for technology integration and focusing on emerging markets could drive substantial growth. As precision medicine continues to advance, the importance of single-cell kits is poised to grow, driving further research and market expansion opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Single Cell Kit Market

The Single Cell Kit Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing advancements in single cell analysis technologies driving demand for more precise single cell kits
    • Growing application of single cell kits in cancer research and personalized medicine boosting market growth
    • Rising government and private funding for single-cell genomics research enhancing kit development
    • Escalating adoption of single cell kits in academic and research institutions for complex biological studies
  • Market Restraints
    • Regulations and ethical concerns surrounding single cell research delay market growth
    • Lack of standardized protocols and procedures impacts the reliability of single cell analysis results
  • Market Opportunities
    • Increasing demand for precision medicine and personalized healthcare is boosting the single cell kit market
    • Rising investment in single-cell genomics research is accelerating the growth of the single cell kit market
    • Technological advancements in single-cell analysis are expanding the applications and adoption of single cell kits
  • Market Challenges
    • Complexity in data management and analysis tools in handling, storing, and interpreting information
    • Lack of standardization in single-cell protocols and workflows

Porter's Five Forces: A Strategic Tool for Navigating the Single Cell Kit Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Single Cell Kit Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Single Cell Kit Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Single Cell Kit Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Single Cell Kit Market

A detailed market share analysis in the Single Cell Kit Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Single Cell Kit Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Single Cell Kit Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Single Cell Kit Market

A strategic analysis of the Single Cell Kit Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Single Cell Kit Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Abcam plc, Agilent Technologies, Becton, Dickinson and Company, Berkeley Lights, Bio-Rad Laboratories, Inc., Dolomite Bio, Fluidigm Corporation, Horizon Discovery, Illumina, Inc., Miltenyi Biotec, Mission Bio, NanoString Technologies, Partek Incorporated, Promega Corporation, QIAGEN, Sphere Fluidics, Takara Bio Inc., Thermo Fisher Scientific Inc., and WaferGen Biosystems.

Market Segmentation & Coverage

This research report categorizes the Single Cell Kit Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Instruments and Reagents And Kits. The Instruments is further studied across Cell Counters, Flow Cytometers, and Microscopes. The Reagents And Kits is further studied across Amplification Kits, Cell Lysis Kits, Library Preparation Kits, and Nucleic Acid Extraction Kits.
  • Based on Technology, market is studied across Next Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR). The Next Generation Sequencing (NGS) is further studied across Exome Sequencing, RNA Sequencing, Single Cell DNA Sequencing, and Whole Genome Sequencing. The Polymerase Chain Reaction (PCR) is further studied across Digital PCR and Real-Time PCR.
  • Based on End User, market is studied across Academic And Research Institutions, Contract Research Organizations, Hospitals And Diagnostic Laboratories, and Pharmaceutical And Biotechnology Companies. The Academic And Research Institutions is further studied across Research Organizations and Universities. The Contract Research Organizations is further studied across Outsourced Research Services. The Hospitals And Diagnostic Laboratories is further studied across Clinical Diagnostics and Pathology Labs. The Pharmaceutical And Biotechnology Companies is further studied across Drug Development and Drug Discovery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing advancements in single cell analysis technologies driving demand for more precise single cell kits
      • 5.1.1.2. Growing application of single cell kits in cancer research and personalized medicine boosting market growth
      • 5.1.1.3. Rising government and private funding for single-cell genomics research enhancing kit development
      • 5.1.1.4. Escalating adoption of single cell kits in academic and research institutions for complex biological studies
    • 5.1.2. Restraints
      • 5.1.2.1. Regulations and ethical concerns surrounding single cell research delay market growth
      • 5.1.2.2. Lack of standardized protocols and procedures impacts the reliability of single cell analysis results
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for precision medicine and personalized healthcare is boosting the single cell kit market
      • 5.1.3.2. Rising investment in single-cell genomics research is accelerating the growth of the single cell kit market
      • 5.1.3.3. Technological advancements in single-cell analysis are expanding the applications and adoption of single cell kits
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in data management and analysis tools in handling, storing, and interpreting information
      • 5.1.4.2. Lack of standardization in single-cell protocols and workflows
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Single Cell Kit Market, by Product Type

  • 6.1. Introduction
  • 6.2. Instruments
    • 6.2.1. Cell Counters
    • 6.2.2. Flow Cytometers
    • 6.2.3. Microscopes
  • 6.3. Reagents And Kits
    • 6.3.1. Amplification Kits
    • 6.3.2. Cell Lysis Kits
    • 6.3.3. Library Preparation Kits
    • 6.3.4. Nucleic Acid Extraction Kits

7. Single Cell Kit Market, by Technology

  • 7.1. Introduction
  • 7.2. Next Generation Sequencing (NGS)
    • 7.2.1. Exome Sequencing
    • 7.2.2. RNA Sequencing
    • 7.2.3. Single Cell DNA Sequencing
    • 7.2.4. Whole Genome Sequencing
  • 7.3. Polymerase Chain Reaction (PCR)
    • 7.3.1. Digital PCR
    • 7.3.2. Real-Time PCR

8. Single Cell Kit Market, by End User

  • 8.1. Introduction
  • 8.2. Academic And Research Institutions
    • 8.2.1. Research Organizations
    • 8.2.2. Universities
  • 8.3. Contract Research Organizations
    • 8.3.1. Outsourced Research Services
  • 8.4. Hospitals And Diagnostic Laboratories
    • 8.4.1. Clinical Diagnostics
    • 8.4.2. Pathology Labs
  • 8.5. Pharmaceutical And Biotechnology Companies
    • 8.5.1. Drug Development
    • 8.5.2. Drug Discovery

9. Americas Single Cell Kit Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Single Cell Kit Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Single Cell Kit Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics
  • 2. Abcam plc
  • 3. Agilent Technologies
  • 4. Becton, Dickinson and Company
  • 5. Berkeley Lights
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Dolomite Bio
  • 8. Fluidigm Corporation
  • 9. Horizon Discovery
  • 10. Illumina, Inc.
  • 11. Miltenyi Biotec
  • 12. Mission Bio
  • 13. NanoString Technologies
  • 14. Partek Incorporated
  • 15. Promega Corporation
  • 16. QIAGEN
  • 17. Sphere Fluidics
  • 18. Takara Bio Inc.
  • 19. Thermo Fisher Scientific Inc.
  • 20. WaferGen Biosystems

LIST OF FIGURES

  • FIGURE 1. SINGLE CELL KIT MARKET RESEARCH PROCESS
  • FIGURE 2. SINGLE CELL KIT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SINGLE CELL KIT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SINGLE CELL KIT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE CELL KIT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SINGLE CELL KIT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SINGLE CELL KIT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SINGLE CELL KIT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SINGLE CELL KIT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SINGLE CELL KIT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE CELL KIT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SINGLE CELL KIT MARKET DYNAMICS
  • TABLE 7. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE CELL KIT MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE CELL KIT MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE CELL KIT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE CELL KIT MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE CELL KIT MARKET SIZE, BY CELL LYSIS KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE CELL KIT MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE CELL KIT MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE CELL KIT MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE CELL KIT MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE CELL KIT MARKET SIZE, BY SINGLE CELL DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE CELL KIT MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE CELL KIT MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE CELL KIT MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE CELL KIT MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE CELL KIT MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE CELL KIT MARKET SIZE, BY OUTSOURCED RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE CELL KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE CELL KIT MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE CELL KIT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 85. CANADA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 86. CANADA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES SINGLE CELL KIT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 142. CHINA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 143. CHINA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 153. INDIA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 154. INDIA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 161. INDONESIA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. JAPAN SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. JAPAN SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 181. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 183. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 192. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 194. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 203. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 205. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 216. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 225. TAIWAN SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TAIWAN SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. TAIWAN SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. TAIWAN SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 236. THAILAND SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. THAILAND SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 238. THAILAND SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 239. THAILAND SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. THAILAND SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 247. VIETNAM SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. VIETNAM SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. VIETNAM SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 250. VIETNAM SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. VIETNAM SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 270. DENMARK SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. DENMARK SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 272. DENMARK SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 273. DENMARK SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 274. DENMARK SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 281. EGYPT SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. EGYPT SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 283. EGYPT SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 284. EGYPT SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. EGYPT SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 292. FINLAND SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. FINLAND SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 294. FINLAND SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 295. FINLAND SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. FINLAND SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 297. FINLAND SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 298. FINLAND SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 299. FINLAND SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 300. FINLAND SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 301. FINLAND SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 302. FINLAND SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 303. FRANCE SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. FRANCE SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. FRANCE SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 306. FRANCE SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 307. FRANCE SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 308. FRANCE SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 309. FRANCE SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. FRANCE SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 311. FRANCE SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 312. FRANCE SINGLE CELL KIT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 313. FRANCE SINGLE CELL KIT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 314. GERMANY SINGLE CELL KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. GERMANY SINGLE CELL KIT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 316. GERMANY SINGLE CELL KIT MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
  • TABLE 317. GERMANY SINGLE CELL KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 318. GERMANY SINGLE CELL KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING (NGS), 2018-2030 (USD MILLION)
  • TABLE 319. GERMANY SINGLE CELL KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 320. GERMANY SINGLE CELL KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 321. GERMANY SINGLE CELL KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 322. GERMANY SINGLE CELL KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)

TA